Clinical Trial Update: A Safety Study to Evaluate the Antiviral Activity of Darunavir in Combination With Ritonavir in HIV 1 Infected Children [Phase 2]

View source ↗

Summary

This Phase 2 safety study evaluated the antiviral activity of darunavir in combination with ritonavir in HIV-1 infected children; study results were posted afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Norvir (ritonavir)
• PREZISTA (darunavir)

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: Human Immunodeficiency Virus 1 | Phase 2 | Status: COMPLETED | Results posted: 2013-06-24